Treatment options for sexual performance issues can vary widely from one man to the next and depending on the severity of his condition. This is because the cause of these conditions can come from just about anything and, of course, every man’s physiology is different, making treatment something which must be tailored and customized to fit each individual person. While treatment approaches are varied, the way in which the problem is best tackled is fairly straight-forward. First, men need to deal with the problem head-on, that is, to find treatments which help them perform as they want. Secondly, long-term treatment options need to identify and deal with the root cause. When it comes to performance issues, the most common is premature ejaculation. This condition can also be the most frustrating as many men don’t bother trying to treat sporadic episodes but instead wait until the condition becomes chronic before they take steps towards improvement. By that time, the conditi…
See all stories on this topic
Erectile dysfunction is a taboo subject among men. No one likes to talk about it. But the fact is that as men age, an increasing number will suffer from erectile dysfunction. From the age of 30, the number of men who have unsatisfactory erections or none at all increases. In the over-60 age group, more than half of all men have been affected by erectile dysfunction. The main causes include cardiovascular disease, diabetes, hormonal imbalance, neurological disease and the side-effects of medication. Even spinal paralysis can result in patients no longer being able to have erections. Some men reach for the ‘blue pills’ to deal with erectile dysfunction. However, Viagra helps only to prolong an erection; it does not actually trigger it. To ‘get it up’, researchers led by Martin Fussenegger, professor of Biotechnology and Bioengineering at the Department of Biosystems (D-BSSE) in Basel, have now developed a novel biotechnological solution: a gene therapy that triggers reliable erections. …
See all stories on this topic
Viagra and other related drugs are not a universal ‘cure-all’ for impotence, according to a new study from The University of Manchester and NatCen Social Research. Drugs, clinically known as oral phosphodiesterase type 5 inhibitors (PDE5i), have become the first-line medical treatment option for sufferers of erectile dysfunction (ED) – also known as impotence – since entering the UK market in 1998. An abundance of studies has demonstrated the effectiveness of such drugs. But researchers at The University of Manchester, who have studied the responses of more than 2,600 English men (aged 50-87 years), suggest that restoring ED pharmacologically is not a ‘cure-all’. Lead author of the study, Dr David Lee, found that older sufferers of ED who had used Viagra, or similar drugs such as Cialis and Levitra, still expressed concern or dissatisfaction with their sex lives. The paper, entitled “Erectile dysfunction and phosphodiesterase type 5 inhibitor use: associations with sexual activities, …
See all stories on this topic
In a study of European men, hypersexuality–a preoccupation with sexual fantasy or an excessive indulgence in sexual activity–correlated with proneness to sexual boredom and problems with erectile function. The study, which included 911 Croatian and 210 German men who were currently in a relationship, contributes to existing knowledge on hypersexuality. The findings indicate that therapies for hypersexual men should include sex therapy principals that may enhance erectile functioning and address sexual boredom. “In some men, hypersexual behavior may serve as a coping mechanism for sexual boredom. In addition, erectile dysfunction within an intimate relationship can accompany this simultaneously,” said Verena Klein, lead author of The Journal of Sexual Medicine study. For full functionality, it is necessary to enable JavaScript. Here are instructions how to enable JavaScript in your web browser. Visit our Sexual Health / STDs category page for the latest news on this subject, or sign …
See all stories on this topic